---
figid: PMC3743069__eht14902
figlink: /pmc/articles/PMC3743069/figure/EHT149F2/
number: F2
caption: Insulin resistance as trigger of atherothrombosis. In subjects with obesity
  or type 2 diabetes the increase in FFA activates TLR leading NF-kB nuclear translocation
  and subsequent up-regulation of inflammatory genes IL-6 and TNF-α. On the other
  hand, JNK and protein kinase C phosphorylate insulin receptor substrate-1 (IRS-1),
  thus blunting its downstream targets PI3-kinase and Akt. This results in down-regulation
  of glucose transporter GLUT-4 and, hence, insulin resistance. Impaired insulin sensitivity
  in the vascular endothelium leads to increased FFA oxidation, ROS formation, and
  subsequent activation of detrimental biochemical pathways such as AGE synthesis,
  PKC activation, protein glicosylation as well as down-regulation of PGI2. These
  events blunt eNOS activity thereby leading to endothelial dysfunction. Lack of insulin
  signalling in platelets impairs the IRS1/PI3K pathway resulting in Ca2+ accumulation
  and increased platelet aggregation. FFA, free fatty acids; TLR, toll-like receptor;
  JNK, c-Jun amino-terminal kinase; IRS-1, Insulin receptor substrate-1; NO, nitric
  oxide; eNOS, endothelial nitric oxide shyntase; IL-6, interleukin-6; TNF-α, tumor
  necrosis factor.
pmcid: PMC3743069
papertitle: 'Diabetes and vascular disease: pathophysiology, clinical consequences,
  and medical therapy: part I.'
reftext: Francesco Paneni, et al. Eur Heart J. 2013 Aug 14;34(31):2436-2443.
pmc_ranked_result_index: '35596'
pathway_score: 0.929866
filename: eht14902.jpg
figtitle: Insulin resistance as trigger of atherothrombosis
year: '2013'
organisms: Homo sapiens
ndex: cc2b12cd-deab-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3743069__eht14902.html
  '@type': Dataset
  description: Insulin resistance as trigger of atherothrombosis. In subjects with
    obesity or type 2 diabetes the increase in FFA activates TLR leading NF-kB nuclear
    translocation and subsequent up-regulation of inflammatory genes IL-6 and TNF-α.
    On the other hand, JNK and protein kinase C phosphorylate insulin receptor substrate-1
    (IRS-1), thus blunting its downstream targets PI3-kinase and Akt. This results
    in down-regulation of glucose transporter GLUT-4 and, hence, insulin resistance.
    Impaired insulin sensitivity in the vascular endothelium leads to increased FFA
    oxidation, ROS formation, and subsequent activation of detrimental biochemical
    pathways such as AGE synthesis, PKC activation, protein glicosylation as well
    as down-regulation of PGI2. These events blunt eNOS activity thereby leading to
    endothelial dysfunction. Lack of insulin signalling in platelets impairs the IRS1/PI3K
    pathway resulting in Ca2+ accumulation and increased platelet aggregation. FFA,
    free fatty acids; TLR, toll-like receptor; JNK, c-Jun amino-terminal kinase; IRS-1,
    Insulin receptor substrate-1; NO, nitric oxide; eNOS, endothelial nitric oxide
    shyntase; IL-6, interleukin-6; TNF-α, tumor necrosis factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - PRKCD
  - PRKCE
  - SLC2A4
  - PRKCB
  - PRKCA
  - DLK1
  - PIK3CA
  - PIK3CB
  - TLR6
  - TLR5
  - TLR8
  - PIK3R3
  - TNF
  - PRKCG
  - PRKD3
  - PI3
  - AKT3
  - TLR10
  - MAPK9
  - PIK3R5
  - PIK3R6
  - TLR7
  - NOS3
  - MAPK10
  - TLR9
  - TLR4
  - PRKCZ
  - PRKCQ
  - PIK3R4
  - MAPK8
  - TLR3
  - AKT2
  - IRS1
  - PIK3CG
  - PRKCI
  - TLR2
  - IKBKB
  - PRKCH
  - PIK3CD
  - TLR1
  - WDR18
  - Cancer
genes:
- word: +IIRS-1/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: '|GLUT-4'
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PG|2
  symbol: pG2
  source: hgnc_alias_symbol
  hgnc_symbol: DLK1
  entrez: '8788'
- word: IRS-1/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: IRS-1/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: IRS-1/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PI3/Akt
  symbol: PI3
  source: hgnc_symbol
  hgnc_symbol: PI3
  entrez: '5266'
- word: +IIRS-1/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: JNK/PKC
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: IRS-1/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: IRS-1/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: JNK/PKC
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: IRS-1/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: JNK/PKC
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: +IIRS-1/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IRS-1/Akt
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IRS-1/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: IKK-B
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: 1JNK/PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: IRS-1/PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: ĮPI3/Akt
  symbol: Ipi3
  source: hgnc_alias_symbol
  hgnc_symbol: WDR18
  entrez: '57418'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3743069__F2
redirect_from: /figures/PMC3743069__F2
figtype: Figure
---
